![Mathias Skalmstad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mathias Skalmstad
Director of Finance/CFO at
DIAMYD MEDICAL AB
Profile
Mathias Skalmstad is currently Chief Financial Officer at Diamyd Medical AB since 2026.
Formerly, Chief Financial Officer at Sprint Bioscience AB from 2011 to 2023.
Education includes an undergraduate degree from Mälardalen University.
Mathias Skalmstad active positions
| Companies | Position | Start |
|---|---|---|
| DIAMYD MEDICAL AB | Director of Finance/CFO | 01/07/2026 |
Former positions of Mathias Skalmstad
| Companies | Position | End |
|---|---|---|
| SPRINT BIOSCIENCE AB | Chief Executive Officer | - |
Training of Mathias Skalmstad
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
10
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Mälardalen University
 Mälardalen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sprint Bioscience AB
 Sprint Bioscience AB Pharmaceuticals: MajorHealth Technology Develops medicines in the field of cancer and metabolism | Health Technology |
Diamyd Medical AB
 Diamyd Medical AB Pharmaceuticals: MajorHealth Technology Develops precision medicine drugs for type 1 diabetes and other forms of autoimmune diabetes | Health Technology |
- Stock Market
- Insiders
- Mathias Skalmstad
